Cargando…
In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants
N-glycosylation has been shown to affect the pharmacokinetic properties of several classes of biologics, including monoclonal antibodies, blood factors, and lysosomal enzymes. In the last two decades, N-glycan engineering has been employed to achieve a N-glycosylation profile that is either more con...
Autores principales: | Kommineni, Vally, Markert, Matthew, Ren, Zhongjie, Palle, Sreenath, Carrillo, Berenice, Deng, Jasmine, Tejeda, Armando, Nandi, Somen, McDonald, Karen A., Marcel, Sylvain, Holtz, Barry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337617/ https://www.ncbi.nlm.nih.gov/pubmed/30621113 http://dx.doi.org/10.3390/ijms20010194 |
Ejemplares similares
-
Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression
por: Roychowdhury, Sugata, et al.
Publicado: (2018) -
Production and N-glycan engineering of Varlilumab in Nicotiana benthamiana
por: Nguyen, Kim Dua, et al.
Publicado: (2023) -
Effects of Kifunensine on Production and N-Glycosylation Modification of Butyrylcholinesterase in a Transgenic Rice Cell Culture Bioreactor
por: Macharoen, Kantharakorn, et al.
Publicado: (2020) -
Glycoform Modification of Secreted Recombinant Glycoproteins through Kifunensine Addition during Transient Vacuum Agroinfiltration
por: Xiong, Yongao, et al.
Publicado: (2018) -
Transient Recombinant Protein Production in Glycoengineered Nicotiana benthamiana Cell Suspension Culture
por: Sukenik, Sara C., et al.
Publicado: (2018)